picasso
New member
Mighty mice hold key to muscle-wasting disease
The first approach, announced this week, aims to use a drug to mop up myostatin. Meanwhile a second method, which is already in clinical trials in people with muscular dystrophy, uses antibodies to disable the protein.
In 1997, researchers led by Se-Jin Lee of Johns Hopkins University School of Medicine in Baltimore, Maryland, engineered mice in which the gene for myostatin had been "knocked out". The animals grew muscles twice as big as normal. A defect in the myostatin gene was what caused a German toddler, whose story was widely publicised last year, to develop prodigious muscles.
- A drug that builds up muscle in mice could be used to treat people suffering from diseases such as muscular dystrophy
The first approach, announced this week, aims to use a drug to mop up myostatin. Meanwhile a second method, which is already in clinical trials in people with muscular dystrophy, uses antibodies to disable the protein.
In 1997, researchers led by Se-Jin Lee of Johns Hopkins University School of Medicine in Baltimore, Maryland, engineered mice in which the gene for myostatin had been "knocked out". The animals grew muscles twice as big as normal. A defect in the myostatin gene was what caused a German toddler, whose story was widely publicised last year, to develop prodigious muscles.